RedHill Biopharma Ltd. - PE Ratio
RDHL
Price:
$0.67
Market Cap:
$2.11M
RedHill Biopharma Ltd. is a specialized pharmaceutical firm concentrating its efforts mainly on therapies for digestive tract conditions and various infections. The company markets several gastrointestinal medications: Movantik, which addresses opioid-induced constipation in adults experiencing chronic non-cancer pain; Talicia, used to treat Helicobacter pylori infections in adult patients; and Aemcolo, prescribed for adults suffering from travelers' diarrhea. Its robust late-stage clinical pipeline features several promising investigational compounds. RHB-204 is currently in Phase 3 for pulmonary nontuberculous mycobacteria infections. Opaganib (Yeliva), an SK2 selective inhibitor, has comp...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2013-01-07
Stock Exchange
NASDAQ
Ticker
RDHL
PE Ratio
[0.13]
ROE
[5.74%]
Current Ratio
[0.34]
Dividend Yield
[0%]
Enterprise Value
[-795286.00]
Dividend History
The PE Ratio as of August 2026 (TTM) for RedHill Biopharma Ltd. (RDHL) is 0.13
According to RedHill Biopharma Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 0.13. This represents a change of -145.22% compared to the average of -0.29 of the last 4 quarters.
RedHill Biopharma Ltd. (RDHL) Historical PE Ratio (quarterly & annually)
How has RDHL PE Ratio performed in the past?
The mean historical PE Ratio of RedHill Biopharma Ltd. over the last ten years is -4.72. The current 0.13 PE Ratio has changed -375.26% with respect to the historical average. Over the past ten years (40 quarters), RDHL's PE Ratio was at its highest in in the June 2023 quarter at 2.50. The PE Ratio was at its lowest in in the March 2016 quarter at -14.11.
Average
-4.72
Median
-5.24
Minimum
-9.51
Maximum
0.79
RedHill Biopharma Ltd. (RDHL) PE Ratio by Quarter and Year
Discovering the peaks and valleys of RedHill Biopharma Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 754.99%
Maximum Annual PE Ratio = 0.79
Minimum Annual Increase = -439.33%
Minimum Annual PE Ratio = -9.51
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -7.58 | 754.99% |
| 2024 | -0.89 | -211.80% |
| 2023 | 0.79 | -439.33% |
| 2022 | -0.23 | -90.94% |
| 2021 | -2.58 | -68.07% |
| 2020 | -8.08 | -6.82% |
| 2019 | -8.67 | 32.81% |
| 2018 | -6.53 | 65.46% |
| 2017 | -3.95 | -58.50% |
| 2016 | -9.51 | -29.86% |
RedHill Biopharma Ltd. (RDHL) Average PE Ratio
How has RDHL PE Ratio performed in the past?
The current PE Ratio of RedHill Biopharma Ltd. (RDHL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-2.56
5-year avg
-2.10
10-year avg
-4.72
RedHill Biopharma Ltd. (RDHL) PE Ratio vs. Peers
How is RDHL’s PE Ratio compared to its peers?
RedHill Biopharma Ltd.’s PE Ratio is greater than IM Cannabis Corp. (-1062.50), greater than Bio Green Med Solution, Inc. (-0.24), greater than CNS Pharmaceuticals, Inc. (-0.18), greater than Akanda Corp. (-0.01), greater than BNB Plus Corp. (-0.00), greater than MSP Recovery, Inc. (-0.00), greater than Flora Growth Corp. (-0.02), greater than GlucoTrack, Inc. (-0.08), greater than Jaguar Health, Inc. (-0.00), greater than 60 Degrees Pharmaceuticals, Inc. (-0.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1062.50 | $385.68K | |
| -0.24 | $2.27M | |
| -0.18 | $3.10M | |
| -0.01 | $162.80K | |
| -0.00 | $210.49K | |
| -0.00 | $1.38K | |
| -0.02 | $4.23M | |
| -0.08 | $297.91K | |
| -0.00 | $70.31K | |
| -0.12 | $983.99K |
Build a custom stock screener for RedHill Biopharma Ltd. (RDHL) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RedHill Biopharma Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
RedHill Biopharma Ltd. (RDHL) and other stocks custom spreadsheet templates
The easiest way to analyze a company like RedHill Biopharma Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is RedHill Biopharma Ltd.'s PE Ratio?
How is the PE Ratio calculated for RedHill Biopharma Ltd. (RDHL)?
What is the highest PE Ratio for RedHill Biopharma Ltd. (RDHL)?
What is the 3-year average PE Ratio for RedHill Biopharma Ltd. (RDHL)?
What is the 5-year average PE Ratio for RedHill Biopharma Ltd. (RDHL)?
How does the current PE Ratio for RedHill Biopharma Ltd. (RDHL) compare to its historical average?